London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Clinical evaluation of a new acrylic microincision intraocular lens

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: IOL Technology / Accommodative IOLs etc.

Session Date/Time: Saturday 13/09/2014 | 16:00-18:00

Paper Time: 17:42

Venue: Boulevard A

First Author: : B.Toygar TURKEY

Co Author(s): :    O. Yabas Kiziloglu   O. Toygar   A. Hacimustafaoglu   K. Keskinbora     

Abstract Details

Purpose:

To assess the safety and efficacy of a new acrylic intraocular lens (IOL) for microincision cataract surgery (MICS). The IOL comprises an acrylic material with a 22% water content, 4 angulated haptics and an aberration-free aspheric optic.

Setting:

Bahçesehir University Faculty of Medical , Medical Park Hospital Göztepe, Istanbul, Turkey

Methods:

A single centre, single surgeon study where 44 eyes (27 patients) were implanted with the MICS IOL (Incise; B+L) following phacoemulsification (Stellaris; B+L). The Viscoject 1.5 inserter was used for IOL implantation. Visual acuity, refraction, average phaco time (APT) and effective phaco time (EPT) were assessed.

Results:

Twenty seven subjects (19 Female; 8 Male) had a mean patient age of 79 ±+7.96 years (range: 57 to 84). Lens power implanted ranged from 18D to 23.5D and incision size ranged from 1.3 to 2.4 mm. A wound-assist implantation technique was used for the 1.3mm incisions. Mean pre-operative corrected visual acuity (CDVA) was 0.7 logMAR (20/100 Snellen). Intra-operatively, median APT was 25.4s, ranging from 5.9s in cataract grade 1+ to 146s in cataract grade 5+. Median EPT was 4.7s (range: 0.6 to 30.5s). At one week post-op (32 eyes), mean CDVA was 0.1±0.06 logMAR (20/25 Snellen) with an average gain of 4 lines. Mean refractive spherical equivalent (MRSE) was -0.30±0.9D. At one month post-op (16 eyes), median CDVA was 0.0 logMAR (20/20) (range: 0.0 to 0.7; one subject with age-related macular degeneration). Median MRSE was -0.2D. Further longer term follow-up data will be presented.

Conclusions:

Early experience finds the Incise IOL is safe and effective, providing a good improvement in visual acuity.

Financial Interest:

One or more of the authors... receives consulting fees, retainer, or contract payments from a competing company, One or more of the authors... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to previous